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Background: Autosomal recessive Long QT syndrome is characterized by prolonged QTc
along with congenital bilateral deafness depends on mutations in Kþ channel genes.
A family of a Long QT syndrome proband from India has been identified with novel indel
variations.
Methods: The molecular study of the proband revealed 4 novel indel variations in KCNQ1. In-
silico analysis revealed the intronic variations has led to a change in the secondary
structure of mRNA and splice site variations. The exonic variations leads to frameshift
mutations. DNA analysis of the available family members revealed a carrier status.
Results and Conclusion: It is thus predicted that the variations may lead to a change in the
position of the splicing enhancer/inhibitor in KCNQ1 leading to the formation of a trun-
cated S2eS3 fragment of KCNQ1 transmembrane protein in cardiac cells as well as
epithelial cells of inner ear leading to deafness and aberrant repolarization causing pro-
longed QTc.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction Autosomal recessive Jervell and Lange Nielsen syndromeCongenital Long-QT syndrome (cLQTS) is an inherited
arrhythmogenic disease characterized on ECG by a prolonged
QTc interval. The ECG manifestation reflects an abnormally
prolonged ventricular action potential, which can be the
substrate for life-threatening arrhythmias that lead to syn-
cope or sudden cardiac death.135; fax: þ91 040 27098020
(P. Nallari).
2013, Cardiological Socie(JLN), characterized by prolonged QTc along with congenital
bilateral deafness depends on homozygous or compound
heterozygous mutations in either KCNQ1 and KCNE1 genes
encoding a potassium channel.2
The coassembly of these two proteins leads to a slowly
activating delayed rectifier potassium channel IKs. KCNQ1
mapped to chromosome 11p15.5, encodes the larger alpha-.
ty of India. All rights reserved.
Fig. 2 e Electrocardiogram of LQTS proband showing a
prolonged QTC of 520 msec.
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tein. KCNQ1 consists of 16 exons, spanning 400 kb, has rela-
tively small amino and carboxy termini, and encodes a protein
of 676 amino acids. Functional IKs channels result from the
coassembly of 4 subunits into a tetrameric protein channel
that is transported to the myocyte membrane. Each subunit
contains 6 membrane-spanning domains (S1 to S6) flanked by
amino and carboxyl terminus regions.3
To date, numerous mutations have been identified across
the coding region of the ion channel genes in JLNS patients but
there is a limited data with respect to the Indian population
most probably because JLNS, being a recessive disease, is far
less prevalent.4 The precise diagnosis in subclinical patients of
LQTS like JLNSwarrantsmolecular analyses in addition to ECG
to establish a genotypeephenotype correlation.5
In the present context, novel compound heterozygous
variations/genetic compounds in a JLN syndrome patient and
family members is reported in KCNQ1 gene with the estab-
lishment of genotypeephenotype correlation.2. Materials and methods
2.1. Clinical evaluation
The proband, a 6-year-old boy of Indian origin, was referred to
the Care Hospitals, Hyderabad with a history of multiple
syncopal attacks due to stress since 6 months of age and
congenital deafness and dumbness. The proband has a 1 year-
old normal sibling and a past history of 2 neonatal and a
sudden infant death in older siblings with history of parental
consanguinity (Fig. 1).
Laboratory investigations of the proband revealed severe
anemia in the proband with a normal blood pressure. The
Echo revealed a Patent Foramen Ovale. The electrocardiogram
(ECG) showed a prolonged QTc of 520 msec (Fig. 2) and diag-
nosed with Long QT syndrome following the diagnostic
criteria of Schwartz et al whereas the ECG of the parents andFig. 1 e Pedigreethe maternal grandparents was found to be normal.6 (The
proband was put on beta-blockers and pacemaker as recom-
mended by the consultant cardiologist.)
Since, JLN syndrome is an autosomal recessive disorder,
peripheral blood samples of the proband and the available
family members (I-3, II-11, II-12, II-13, III-28, IV-38, IV-42) were
collected for DNA analyses after obtaining Institutional Ethics
Committee, Dept. of Genetics, Osmania University, India
clearance and informed written consent from the proband
and his family members. 100 control blood samples without
any history of cardiovascular or systemic conditions were
collected from Osmania General Hospital, Hyderabad for
comparative analysis.
2.2. Molecular analyses
Genomic DNA was isolated from peripheral blood samples by
following standard protocols in 100 controls proband and his
family members. The DNA sequences corresponding to
KCNQ1 gene and KCNE1 gene were amplified using the primer
sets as described by Syrris et al.7 Fragments were amplified onof proband.
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 5 5 2e5 6 0554Eppendorf Thermal cycler Gradient in the presence of 1 U Taq
DNA polymerase, 0.2 mM deoxyribonucleotide, 1.5 mMMgCl2,
100 ng forward and reverse primers and genomic DNA and the
PCR products were subsequently screened by Single Stranded
Conformational Polymorphism (SSCP) according to standard
procedures and the gels were visualized with silver-staining.
2.3. In-silico analysis
The DNA samples exhibiting a variation in the SSCP pattern
were commercially sequenced and the mutations identified
were subjected to in-silico analysis to elucidate the effect of
the variation on the primary, secondary, 3D and the trans-
membrane structure of the protein. In-silico analysis was also
carried out to elucidate the mRNA secondary structure
changes, splice site changes and the possible binding site
variations for SnRNP’s involved in spliceosome formation
caused by the intronic and exonic variations.3. Results
3.1. Molecular results
The SSCP patterns variations were observed in the proband,
his parents, sibling and his maternal grandmother only in the
Exons 3 and 4 of KCNQ1 gene (Fig. 3A and B). KCNE1 has also
been screened simultaneously to identify variations, however,
no variations were observed in KCNE1 gene.
On commercial sequencing, the electropherogram of the
proband revealed variations in Intron 3, Exon 3 and Exon 4 ofFig. 3 e A: SSCP pattern of Exon-3 of KCNQ1 Lane 1e8 in
order (from left): Control, proband, father, mother, sibling,
maternal grandmother, maternal grandfather, paternal
grandmother. B: SSCP pattern of Exon-4 of KCNQ1 Lane 1e8
in order (from left): Control, maternal grandmother,
maternal grandfather, paternal grandmother, proband,
father, mother and sibling.
Fig. 4 e (AeG): Electropherogram of control (A) and mutant
(B) revealed the deletion of ‘G’ at L20 and insertion of
‘CAAGG’ between L19 and L18 upstream of Exon 3 i.e. in
Intron 3. electropherogram of control (C) and mutant (D)
revealing an insertion of ‘ATC’ in Exon 3. electropherogram
of control (E) and mutant (F) showing the deletion of ‘G’ in
Exon 4, the chromatogram of maternal heterozygous
sample (G), paternal heterozygous sample (H), sibling
heterozygous sample (I).
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 5 5 2e5 6 0 555KCNQ1 gene for which a reference SNP number (rs number)
was registered with dbSNP.
The NCBI BLAST revealed the following homozygous
variations:
1) Deletion of ‘G’ (IVS3-20delG) [rs181951164] (Fig. 4A and B),
2) An insertion of ‘CAAGG’ (IVS3-18_-19insCAAGG) in Intron 3
[rs187358307] (Fig. 4A and B),
3) An insertion of ‘ATC’ (2531968_2531969insATC) in Exon 3
of KCNQ1 [rs191143265] (Fig. 4C and D), and
4) A deletion of ‘G’ (2532597delG) in Exon 4 of KCNQ1
[rs182975255] (Fig. 4E and F).
While the electropherograms of the parents, sibling and
maternal grandmother revealed a carrier status of the
sequence (Fig. 4G).3.2. In-silico analysis
3.2.1. Splice site prediction
Splice site analysis was carried out using the online tool www.
cbs.dtu.dk/services/NetGene2/ to evaluate the effect of genetic
variations wherein predictions revealed a change in the posi-
tion of the splice site. The donor splice site changed from100th
position to 104th position and the acceptor splice site changed
from 15th position to 19th position in the mutant (Table 1).
3.2.2. Splicing rainbow prediction
Since, thevariation lies close to thedonor splice site, it ispossible
that it could be a part of a possible binding site for SnRNP’s
involved in spliceosome formation. The sequencewas therefore
subjected to splicing rainbow software EBI Databases ASD
ALTERNATIVE SPLICING (www.ebi.ac.uk/asd-srv/wb.cgi) (Fig. 5).
Splicing rainbow analysis revealed that the variation lies in
a putative binding site for hnRNP.I, hnRNP.K, SRp20, SRp40,
SRp55, ASF/SF2 and SC35 which clearly highlights the altered
regulation (Table 2).
3.2.3. RNA secondary structure prediction
Since, the variation lies in the intronic sequence, the RNA
secondary structure predicted using GENEBEE software
(Table 3) revealed the free energy of the mRNA in the mutant
structure (46.5 kkal/mol) to be lower than that of the wild-Table 1 e Splice site predictions.
Wild
Donor site predictions
Start End Score Exon Intron
100 114 0.77 gcagcaagtacgtgg
156 170 0.99 atcatcggtgagtca
Acceptor site predictions:
Start End Score Intron Exon
15 55 0.83 cgtcccactctgtccctgca
ggagatcgtgctggtggtgtt
Acceptor and donor sites-in bold.type mRNA secondary structure (35.9 kkal/mol), with the
stabilization increasing manifold. The free energies of the
mRNA stems of the mutant did not match with the wild-type.
The mutation has apparently altered the mRNA secondary
structure resulting in a truncated protein.3.3. Protein structure prediction of Exon 3 variation
In-silicostudies revealed that the insertionofacodon in theExon
3 of KCNQ1may lead to the addition of an amino acid, Isoleucine
after the 42nd amino acid ( p.Ilu201_Asp202insIlu) in the protein
primary structure prediction (http://asia.ensembl.org).
3.3.1. Wild type protein primary structure encoded by 3rd
exon
EIVLVVFFGTEYVVRLWSAGCRSKYVGLWGRLRFARKPISII.
3.3.2. Mutant protein primary structure encoded by 3rd exon
EIVLVVFFGTEYVVRLWSAGCRSKYVGLWGRLRFARKPISIII.
3.3.3. Wild type protein secondary structure encoded by 3rd
exon
The primary protein structures were subjected to the sec-
ondary structure prediction tool i.e. The PSIPRED (http://
bioinf.cs.ucl.ac.uk/psipred/).
3.3.4. Mutant protein secondary structure encoded by 3rd
exon
The protein secondary structure prediction revealed an in-
crease in coils due to the addition of an amino acid when
compared to the wild type (Fig. 6A and B).3.4. Protein structure prediction of Exon 4 variation
3.4.1. Wild type protein primary structure encoded by 4th
exon
DLIVVVASMVVLCVGSKGQVFATSAI.
3.4.2. Mutant protein primary structure encoded by 4th exon
DLIVVVASMVVLCVAPRGRCCHVGHQ.
The protein primary structure prediction shows that the
deletion of a nucleotide ‘G’ (2532597delG) leads to a frameshiftMutant
Donor site predictions
Start End Score Exon Intron
104 118 0.77 gcagcaagtacgtgg
163 177 0.99 atcatcggtgagtca
Acceptor site predictions:
Start End Score Intron Exon
19 59 0.68 aggcccactctgtccctgcag
gagatcgtgctggtggtgtt
Fig. 5 e The change in binding sites of various proteins. As seen clearly there is change in binding sites of various proteins
(A-wild type and B-mutant) that play a role in regulation (refer Table 2).
Table 2 e The variation (indicated in red) in binding sites of various spliceosome complex proteins between wild type and
mutant. As seen clearly there is variation and also creation of new binding sites of various proteins that play a role in
regulation.
Protein Wild Mutant 
hnRNP. I CGTCCCACTCTGTCCCTGC CCCACTCTGTCCCTGC
hnRNP.K TCCCAC GCCCAC
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Table 3 e RNA secondary structure prediction.
Control Mutant
Stem- 1 with energy e 14.600000 Kkal/mol Stem- 1 with energy e 18.400000 Kkal/mol
7 13 CCTGCAG 22 29 AGGCCCAC
39 33 GGACGTC 125 118 TCCGGGTG
Stem- 2 with energy e 13.100000 Kkal/mol Stem- 2 with energy e 11.700000 Kkal/mol
126 130 GGGCG 33 37 GTCCC
198 194 CCCGC 71 67 CAGGG
Stem- 3 with energy e 10.800000 Kkal/mol Stem- 3 with energy e 11.100000 Kkal/mol
86 91 CTGGTC 130 133 GGGC
213 208 GACCAG 148 145 CCCG
Stem- 4 with energy e 9.200000 Kkal/mol Stem- 4 with energy e 9.200000 Kkal/mol
64 67 GGAC 196 199 GGTC
81 78 CCTG 218 215 CCAG
Stem- 5 with energy e 8.800000 Kkal/mol Stem- 5 with energy e8.100000 Kkal/mol
97 100 GCTG 149 152 GGAA
107 104 CGAC 162 159 CCTT
Stem- 6 with energy e 8.100000 Kkal/mol Stem- 6 with energy e 7.800000 Kkal/mol
145 148 GGAA 86 88 GCC
158 155 CCTT 102 100 CGG
Stem- 7 with energy -7.400000 Kkal/mol Stem- 7 with energy e 7.700000 Kkal/mol
93 95 GCC 18 21 CTCA
119 117 CGG 177 174 GAGT
Stem- 8 with energy e 6.500000 Kkal/mol Stem- 8 with energy e 7.700000 Kkal/mol
176 178 CCT 10 13 GCAG
190 188 GGA 187 184 CGTC
Stem- 9 with energy e 6.400000 Kkal/mol Stem- 9 with energy e 7.200000 Kkal/mol
123 125 TGG 75 78 GTAC
207 205 ACC 117 114 CATG
Stem- 10 with energy e 6.300000 Kkal/mol Stem- 10 with energy e 6.400000 Kkal/mol
131 132 GC 39 41 GCA
142 141 CG 52 50 CGT
Stem- 11 with energy e 6.200000 Kkal/mol Stem- 11 with energy e 6.200000 Kkal/mol
167 169 TGA 103 105 TGC
193 191 ACT 112 110 ACG
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Fig. 6 e A: Wild type protein secondary structure encoded
by 3rd exon. B: Mutant protein secondary structure
encoded by 3rd exon. C: Wild type protein secondary
structure encoded by 4th exon. D: Mutant protein
secondary structure encoded by 4th exon.
Fig. 7 e A: 3D structure of mutant protein. B: 3D structure of
wild type protein.
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 5 5 2e5 6 0558mutation from the site of deletion in the Exon 4 of KCNQ1
leading to p.Ala216fs.
3.4.3. Wild type protein secondary structure encoded by 4th
exon
The primary protein structures were subjected to the sec-
ondary structure prediction tool i.e. The PSIPRED (http://
bioinf.cs.ucl.ac.uk/psipred/).
3.4.4. Mutant protein secondary structure encoded by 4th
exon
The secondary protein structure prediction of Exon 4 indicates
a completely altered secondary structure of the protein withan increase in coils and reduction in the strands of the protein
when compared to the wild type (Fig. 6C and D).
3.5. 3-Dimensional structure prediction of KCNQ1
protein
The assembly of the complete KCNQ1 protein when compared
to the wild type structurewas different with the incorporation
of the variant amino acids wherein an increase in number and
size of beta sheets was associated with a reduction in size of
alpha-helices and replacement of alpha-helices by beta
sheets which contributed to an increase in size of loops
(Fig. 7A and B).
3.6. Transmembrane structure prediction of KCNQ1
Since, KCNQ1 is a transmembrane potassium channel protein
and Exon 3 and 4 encode the S2 and S2eS3 transmembrane
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 5 5 2e5 6 0 559domains of KCNQ1, respectively; the effect of frameshift mu-
tations on the transmembrane structure of KCNQ1 could be
predicted (The PSIPRED http://bioinf.cs.ucl.ac.uk/psipred/).
The software tool predicted a decrease in number of the
transmembrane domains with the S4 transmembrane domain
being lost, truncated S2eS3 fragment formation and the N-
terminal position shifted from intracellular to extracellular re-
gion of KCNQ1when compared to the wild type (Fig. 8A and B).4. Discussion
The proband referred as a 6-year-old boy was categorized as a
patient of JLN syndrome a recessive form of Long QT
syndrome based on the clinical diagnostic criteria with a
history of parental consanguinity, neonatal sibling deaths,
age at onset of 6 months and deafness associated with mu-
tations in KCNQ1 gene.8,9 Mutations associated with JLN syn-
drome were also reported in Chinese families and other
populations.3,5,10e13
KCNQ1 encodes for potassium channel proteins and is
primarily localized to the membrane spanning domains and
the pore region affecting the heart, inner ear leading to pro-
longed QTc and deafness.14,15
The study reports novel genetic variations in the Intron 3,
Exon 3 and Exon 4 of KCNQ1 in a 6-year-old proband of IndianFig. 8 e A: Transmembrane structure of wild-type protein. B: tr
variations) protein.origin. The patient harboring the homozygous recessive var-
iations has a history of syncope triggered by exercise/
emotional stress while the parents, sibling and grandparents
of the proband were asymptomatic, but their electrophero-
grams revealed a heterozygosity for the variation. The present
study is the first to report on compound heterozyosity/genetic
compounds in the proband.
In-silico analysis revealed variations in splice site scores,
mRNA secondary structure, hnRNPs and SR proteins binding
sites clearly pin-pointing to altered gene regulation associated
with protein structure and function variations.
Further, the 3D structure alterations observed by In-silico
analysis emphasize an increase in number of beta sheets,
loops and decrease in number and length of alpha helices
leading to a truncated protein. The aberrant channel may lead
to abnormal secretion of potassium in the endolymph of the
scala media, which is necessary for normal hearing thus,
leading to deafness in the proband.16e18
This can be explained on the basis of localization of trans-
membrane channel with altered shift in N-terminal position
and a loss of S4 fragment and truncated S2eS3 fragment. The
impact of genetic variations on the protein clearly establishes
the potassium channel defects causing JLN syndrome with the
impaired efflux of potassium affecting the heart and ear. The
study also lays emphasis on the developmental gene implica-
tions and the epigenetic modifications of these genes in theansmembrane structure of mutant (Exon 3 D Exon 4
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 5 5 2e5 6 0560onset of JLN syndrome. The pathogenic nature of these varia-
tions needs to be elucidated by functional studies.5. Conclusion
We report a JervelleLange Neilson syndrome with congenital
deafness, prolonged QTc, family history of sudden deaths,
consanguinity and compound heterozygosity in KCNQ1. The
electropherogram of the parents, sibling and maternal grand-
mother revealed a heterozygous state while the variations in
the proband are present in a recessive form. In-silico analysis
also revealed the variations may lead to a change in the sec-
ondary structure of mRNA and changes the position of splice
site. The variations also lead to a change in the position of the
splicing enhancer/inhibitor in KCNQ1 and exonic variations
may lead to the formation of a truncated S2eS3 fragment of
KCNQ1 transmembrane protein in cardiac cells as well as
epithelial cells of inner ear leading to deafness and aberrant
repolarization causing prolonged QTc. Functional studies are
warranted to elucidate the pathogenic nature of the variations.Ethics committee approval
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